Back to top

Zacks.com Most Recent Articles

Zacks Equity Research

Zeta Global Holdings (ZETA) Tops Q1 Earnings and Revenue Estimates

Tale of the Tape

Zeta (ZETA) delivered earnings and revenue surprises of +10.50% and +7.10%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

ZETAPositive Net Change SYMPositive Net Change

Sheraz Mian

How to Make the Most of Today's Market

Weekend Wisdom

Is the worst behind us? Is the Fed's next move to cut rates or raise them? These are just a couple of the issues that divide the bulls and the bears at the moment. Sheraz Mian weighs both viewpoints to determine the outlook most favorable for investors moving forward.

Zacks Equity Research

LyondellBasell (LYB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Fundamental Analysis

While the top- and bottom-line numbers for LyondellBasell (LYB) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

LYBPositive Net Change

Urmimala Biswas

Should You Buy, Hold, or Sell IonQ Stock Before Q1 Earnings?

Analyst Blog

IONQ faces a crucial Q1 test as strong revenue growth and backlog meet high valuation, macro pressure, and ongoing losses ahead of May 6 results.

IONQPositive Net Change RGTINegative Net Change QBTSPositive Net Change

Zacks Equity Research

GDDY Q1 Earnings beat, Revenues Rise Y/Y on Strong Airo Execution

Analyst Blog

GoDaddy's Q1 beat is fueled by Airo-led execution, with faster monetization, ARPU up 9.3% y/y to $246, and stronger margins and cash flow.

MKSINegative Net Change AEISPositive Net Change GDDYNegative Net Change AEYEPositive Net Change

Zacks Equity Research

Linde Q1 Earnings Beat Estimates, Revenues Rise Y/Y, Dividend Raised

Analyst Blog

LIN's bottom line beat Q1 estimates as pricing and project start-ups drive growth, with revenues up 8% and EPS rising 10% year over year.

DOWPositive Net Change CFNegative Net Change LINPositive Net Change NTRNegative Net Change

Zacks Equity Research

Aon Q1 Earnings Beat Estimates on Strong Risk Capital Growth

Analyst Blog

Aon posts Q1 earnings beat as Risk Capital strength and margin gains drive growth, offset partly by weaker Wealth Solutions performance.

AIGPositive Net Change AXSNegative Net Change AONPositive Net Change SIGINegative Net Change

Zacks Equity Research

KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration

Analyst Blog

Kymera Therapeutics tops Q1 revenue estimates on strong Gilead collaboration, as pipeline advances and KT-200 milestone deal boost outlook.

SNYNegative Net Change GILDPositive Net Change CSTLPositive Net Change KYMRNegative Net Change

Zacks Equity Research

Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?

Analyst Blog

Gilead Sciences gears up for Q1 earnings with HIV drugs driving growth, but cell therapy headwinds and rising costs could shape the outlook.

GSKNegative Net Change MRKPositive Net Change GILDPositive Net Change

Urmimala Biswas

National Quantum Policy Bill Advances: IBM, IonQ, Cisco in Focus

Analyst Blog

IBM stands to gain as a new U.S. quantum bill shifts focus to commercialization, funding clarity, and real-world deployment starting as early as 2026.

IBMPositive Net Change CSCOPositive Net Change IONQPositive Net Change